FDA clears 3-D printed device; Covidien opens center of innovation in Brazil;

@FierceMedDev: ICYMI yesterday: NY Senators tell FDA to stop sales of power morcellators. Article | Follow @FierceMedDev

@VarunSaxena2: Russian scientists close in on drug-delivering nanorobots. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: Chinese hackers infiltrate U.S. health care system as China's medical device industry booms. Bloomberg story | Follow @EmilyWFierce

> Oxford Performance Materials received an FDA clearance for 3D printed OsteoFab Patient-Specific Facial Device. Release

> Covidien's ($COV) Center of Innovation opened in Brazil to promote growth in the emerging market. Release

> DSM launched a new cellular therapy development therapy in efforts to expand biomedical department. Release

> Cardiva Medical closes two rounds of Series 3 private equity financing after raising $16.5 million. Release

> Ultrasound healing technology company Celleration received FDA clearance for the latest addition to the Mist Therapy product line. Release

Biotech News

@FierceBiotech: Lilly joins the list of Enbrel-beaters with head-to-head psoriasis showdown. News | Follow @FierceBiotech

@JohnCFierce: Global fear of Ebola outbreak stokes a frenzy of new R&D, production plans. More | Follow @JohnCFierce

@DamianFierce: ICYMI yesterday: $FOLD CEO on positive new migalastat data, next-gen Fabry treatment and the importance of perseverance. Report | Follow @DamianFierce

@EmilyMFierce: Parents more likely to vaccinate kids against measles when child's, not society's, benefits are stressed. FierceVaccines story | Follow @EmilyMFierce

> J&J, AstraZeneca and Sanofi join Illumina to create a pan-cancer test. Story

> Baxter's next hemophilia drug clocks a Phase III success. More

> GlaxoSmithKline grabs FDA approval for its latest asthma treatment. Article

Pharma News

@FiercePharma: Top-read on FP Weds: Don't worry about a hep C pricing war, analysts tell Gilead-watchers. Article | Follow @FiercePharma

@TracyStaton: Been on vacay? @FiercePharma's top August news so far: Pfizer faces growing legal threat over Lipitor. Story | Follow @TracyStaton

@EricPFierce: FDA warning letter for India's Marck Biosciences lays out in vivid detail why it banned it plant. More | Follow @EricPFierce

@CarlyHFierce: @US_FDA approves first needle-free flu vaccine injection system. Story | Follow @CarlyHFierce

> Massive Novo insulin plant aims to make more with less. Story

> Pfizer eyes Actavis in backup plan to another AstraZeneca bid. Article

> Mylan, private equity, Indian pharmas to compete for cast-off GSK brands. More

Vaccines News

> Measles vaccination more likely when child's, not society's, benefits are stressed. Report

> Report: Takeda's dengue jab will be nipping at Sanofi's heels by 2020. More

> Chikungunya vaccine protects against virus in small Phase I study. Article

> FDA approves first needle-free flu vaccine injection system. More

> Clinical failure for Merck KGaA's cancer vaccine dents subpopulation hopes. Story

Pharma Manufacturing News

> Pfizer recalls nearly 94,000 vials of Depo-Medrol. Item

> Novo cutting emissions while building capacity at massive Denmark plant. Report

> Lonza gets a break on the tax break it got for the U.S. plant it is closing. More

> Hikma seizes on 'opportunities' for injectables growth. Article

> DOJ investigates Dr. Reddy's for failing to protect children with packaging. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.